Allison, J.G., P.M. Das, J. Ma, F.M. Inglis, and F.E. Jones. 2011. The ERBB4 intracellular domain (4ICD) regulates gene expression in hippocampal cells. Neuroscience Research 70:155-163.
Cittelly, D.M., N.S. Spoelstra, S.M. Edgerton, J.K. Richer, A.D. Thor, and F.E. Jones. 2010. Suppression of miR-342 expression contributes to anti-estrogen resistance in breast tumor cells. Molecular Cancer 9:317.
Cittelly, D.M., P.M. Das, V.A. Salvo, J.P. Fonseca, M.E. Burow, and F.E. Jones. 2010. Oncogenic HER2D16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors. Carcinogenesis 31:2049-2057.
Das, P.M., A.D. Thor, S.M. Edgerton, S.K. Barry, D.F. Chen, and F.E. Jones. 2010. Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells. Oncogene 29:5214-5219.
Rokicki, J., P.M. Das, J.M. Giltnane, O. Wansbury, A. Naresh, D.L. Rimm, B.A. Howard, and F.E. Jones. 2010. The ERa coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium. Molecular Cancer 9:150.
Thor, A.D., S.M. Edgerton, and F.E. Jones. 2009. Subcellular localization of the HER4 intracellular domain, 4ICD, identifies distinct prognostic outcomes for breast cancer patients. The American Journal of Pathology 175:1802-1809.
Mitra, D., M.J. Brumlik, S.U. Okamgba, T.T. Tyson, J. Parvani, E. Brogi, and F.E. Jones. 2009. An oncogenic isoform of HER2 promotes metastatic breast cancer and trastuzumab resistance. Molecular Cancer Therapeutics 8:2152-2162. Received "Editor Highlight" honors.
Naresh, A., A.D. Thor, S.M. Edgerton, K.C. Torkko, R. Kumar, and F.E. Jones. 2008. The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis. Cancer Research 68:6387-6395. Received journal cover honors.
Gullick, W.J. and F.E. Jones. 2008. The epidermal growth factor family of ligands and receptors grows and grows. Journal of Mammary Gland Biology and Neoplasia 13:157.
Jones, F.E. 2008. HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer. Journal of Mammary Gland Biology and Neoplasia 13:247-258. Received journal cover honors.
Kirkegaard, T., A. Naresh, V.S. Sabine, S.M. Tovey, J. Edwards, B. Dunne, T.G. Cooke, F.E. Jones*, and J.M.S. Bartlett*. 2008. Expression of tumor necrosis factor-a converting enzyme (TACE) in endocrine cancers. American Journal of Clinical Pathology 129:735-743. *Indicates shared corresponding authors.
Vidal, G.A., D.E. Clark, L. Marrero, and F.E. Jones. 2007. A constitutively active ERBB4/HER4 mutant with enhanced apoptotic and transcriptional co-activation activities. Oncogene 26:462-466.
Zhu, Y., L.L. Sullivan, S.S. Nair, C.C. Williams, A. Pandy, L. Marrero, R.K. Vadlamudi, and F.E. Jones. 2006. Coregulation of estrogen receptor by estrogen-inducible ERBB4/HER4 establishes a growth promoting autocrine signal in breast cancer. Cancer Research 66:7991-7998.
Naresh, A., W. Long, G.A. Vidal, A., W.C. Wimley, L. Marrero, C.I. Sartor, S. Tovey, T.G. Cooke, J.M.S. Bartlett, and F.E. Jones. 2006. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. Cancer Research66:6412-6420.
Clark, D.E., C.C. Williams, T.T. Duplessis, K.L. Moring, A.R. Notwick, W.S. Lane, I. Beuvink, N.E. Hynes, and F.E. Jones. 2005. ERBB4/HER4 potentiates STAT5A transcriptional activity by regulating novel STAT5A serine phosphorylation events. The Journal of Biological Chemistry. 280: 24175-24180.
Vidal, G.A., A. Naresh, L. Marrero, and F.E. Jones. 2005. Presenilin-dependent g-secretase processing regulates multiple ERBB4/HER4 activities. The Journal of Biological Chemistry. 280:19777-19783.
Williams, C.C., J.G. Allison, G.A. Vidal, M.E. Burow, B.S. Beckman, L. Marrero, and F.E. Jones. 2004. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. The Journal of Cell Biology 167:469-478. Received journal cover honors.
Zhu, Y. and F. E. Jones. 2004. Expression and activation of ErbB signaling in the mouse prostate. The Prostate 60:68-75.
Jones, F. E., Golding, J. P., and Gassmann, M. 2003. ErbB4 signaling during breast and neural development: Novel genetic models reveal unique ErbB4 activities. Cell Cycle 2:61-65.
Long, W., K.-W. Wagner, K. C. K. Lloyd, N. Binart, J. M. Shillingford, L. Hennighausen, and F. E. Jones. 2003. Impaired differentiation and lactational failure in ErbB4-deficient mammary glands identify ErbB4 as an obligate mediator of Stat5. Development 130:5257-5268.
Jones, F. E., Burow, M. E. and Hill, S. M. 2003. Signal transduction in breast cancer: silencing the cross-talk. Eur. Biopharmaceutical Rev. Spring:70-73.
Li, L., S. Cleary, M. Mandarano, C. Birchmeier, and F. E. Jones. 2002. The breast proto-oncogene, HRGa regulates epithelial proliferation and lobuloalveolar functional development in the mouse mammary gland. Oncogene 21:4900-4907.
